TDEIX
Price
$35.75
Change
+$0.07 (+0.20%)
Updated
Dec 3 closing price
Net Assets
2.93B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

TDEIX vs VIGRX

Header iconTDEIX vs VIGRX Comparison
Open Charts TDEIX vs VIGRXBanner chart's image
Transamerica US Growth I
Price$35.75
Change+$0.07 (+0.20%)
VolumeN/A
Net Assets2.93B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
TDEIX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
TDEIX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TDEIX is a StrongBuy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. TDEIX (2.93B). VIGRX pays higher dividends than TDEIX: VIGRX (0.30) vs TDEIX (0.00). TDEIX was incepted earlier than VIGRX: TDEIX (16 years) vs VIGRX (33 years). TDEIX (0.77) is less costly to investors than VIGRX (0.17). TDEIX is a more actively managed with annual turnover of: 36.00 vs. VIGRX (11.00). VIGRX has a lower initial minimum investment than TDEIX: VIGRX (3000) vs TDEIX (1000000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. TDEIX (1.91). VIGRX return over 5 years is better than : 99.11 vs. TDEIX (19.09).
TDEIXVIGRXTDEIX / VIGRX
Total Expense Ratio0.770.17453%
Annual Report Gross Expense Ratio0.770.17453%
Fund Existence16 years33 years-
Gain YTD18.49519.76494%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets2.93B357B1%
Annual Yield % from dividends0.000.30-
Returns for 1 year1.9118.4910%
Returns for 3 years61.25110.8255%
Returns for 5 years19.0999.1119%
Returns for 10 years100.55349.1329%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT